Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: Post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

Critical Care

Volumn 11, Issue , 2007, Pages

  Kluger, Yoram ^a   Riou, Bruno ^b   Rossaint, Rolf ^c   Rizoli, Sandro B ^d   Boffard, Kenneth David ^e   Choong, Philip Tsau ^f   Warren, Brian ^g   Tillinger, Michael ^h  

^a RAMBAM MEDICAL CENTER   (Israel)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^g STELLENBOSCH UNIVERSITY   (South Africa)

^h NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; MALE; MORTALITY; MULTIPLE TRAUMA; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TRAUMATIC BRAIN INJURY; VEIN THROMBOSIS; BLEEDING; BLUNT TRAUMA; BRAIN INJURY; DOSE RESPONSE; MULTICENTER STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BRAIN INJURIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FACTOR VIIA; FEMALE; HEMORRHAGE; HEMOSTATICS; HUMANS; MALE; MULTIPLE TRAUMA; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TREATMENT OUTCOME; WOUNDS, NONPENETRATING;

EID: 34548295999     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6092     Document Type: Article

References (56)

1. Centers for Disease Control and Prevention (CDC) Rates of hospitalization related to traumatic brain injury - nine states, 2003 MMWR Morb Mortal Wkly Rep 2007 56 167-170 17332728
2. Hoyt DB A clinical review of bleeding dilemmas in trauma Semin Hematol 2004 41 40-43 10.1053/j.seminhematol.2003.11.009 14872420
3. Sauaia A Moore FA Moore EE Moser KS Brennan R Read RA Pons PT Epidemiology of trauma deaths: A reassessment J Trauma 1995 38 185-193 7869433
4. Hoyt DB Bulger EM Knudson MM Morris J Ierardi R Sugerman HJ Shackford SR Landercasper J Winchell RJ Jurkovich G Death in the operating room: An analysis of a multi-center experience J Trauma 1994 37 426-432 8083904
5. Koh MB Hunt BJ The management of perioperative bleeding Blood Rev 2003 17 179-185 10.1016/S0268-960X(02)00062-0 12818228
6. Grounds M Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review Blood Rev 2003 17 S11-S21 10.1016/S0268-960X(03)90002-6 14697209
7. Lynn M Jeroukhim I Klein Y Martinowitz U Updates in the management of severe coagulopathy in trauma patients Intensive Care Med 2002 28 S241-S247 10.1007/s00134-002-1471-7 12404093
8. Dutton RP McCunn M Hyder M D'Angelo M O'Connor J Hess JR Scalea TM Factor VIIa for correction of traumatic coagulopathy J Trauma 2004 57 709-718 15514523
9. Martinowitz U Kenet G Segal E Luboshitz J Lubetsky A Ingerslev J Lynn M Recombinant activated factor VII for adjunctive hemorrhage control in trauma J Trauma 2001 51 431-438 11535886
10. Martinowitz U Michaelson M Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force J Thromb Haemost 2005 3 640-648 10.1111/j.1538-7836.2005.01203.x 15842347
11. Harrison TD Laskosky J Jazaeri O Pasquale MD Cipolle M "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage J Trauma 2005 59 150-154 16096555
12. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Anesthesiology 2006 105 198-208 10.1097/00000542-200607000-00030 16810012
13. Spahn DR Cerny V Coats TJ Duranteau J Fernández-Mondéjar E Gordini G Stahel PF Hunt BJ Komadina R Neugebauer E Task Force for Advanced Bleeding Care in Trauma Management of bleeding following major trauma: A European guideline Crit Care 2007 11 R17 10.1186/cc5686 17298665
14. Rizoli S Nascimento B Osman F Netto FS Kiss A Callum J Brenneman FD Tremblay L Tien HC Recombinant activated coagulation factor VII and bleeding trauma patients J Trauma 2006 61 1419-1425 17159685
15. Vincent JL Rossaint R Riou B Ozier Y Zideman D Spahn DR Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective Crit Care 2006 10 R120 1750973 16919168 10.1186/cc5026
16. Boffard KD Riou B Warren B Choong PI Rizoli S Rossaint R Axelsen M Kluger Y NovoSeven Trauma Study Group Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials J Trauma 2005 59 8-15 16096533
17. Dereeper E Ciardelli R Vincent JL Fatal outcome after polytrauma: multiple organ failure or cerebral damage? Resuscitation 1998 36 15-18 10.1016/S0300-9572(97)00080-4 9547838
18. Søreide E Deakin CD Pre-hospital fluid therapy in the critically injured patient - a clinical update Injury 2005 36 1001-1010 10.1016/ j.injury.2005.01.002 16098325
19. Maas AIR Dearden M Teasdale GM Braakman R Cohadon F Iannoti F Karimi A Lapierre F Murray G Ohman J EBIC guidelines for management of severe head injury in adults Acta Neurichir 1997 139 286-294 10.1007/BF01808823
20. Vincent JL Berré J Primer on medical management of severe brain injury Crit Care Med 2005 33 1392-1399 10.1097/ 01.CCM.0000166890.93559.2D 15942361
21. Mayer SA Brun NC Begtrup K Broderick J Davis S Diringer MN Skolnick BE Steiner T Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 2005 352 777-785 10.1056/ NEJMoa042991 15728810
22. Hawryluk GW Cusimano MD The role of recombinant activated factor VII in neurosurgery: Hope or hype? J Neurosurg 2006 105 859-868 17405256
23. Zaaroor M Bar-Lavie Y The use of recombinant factor VIIa in head injury: a report of five cases Semin Hematol 2004 41 1 Suppl 1 175-176 10.1053/ j.seminhematol.2003.11.033
24. Morenski JD Tobias JD Jimenez DF Recombinant activated factor VII for cerebral injury-induced coagulation in pediatric patients. Report of three cases and review of the literature J Neurosurg 2003 98 611-616 12650436
25. Park P Fewel ME Garton HJ Thompson G Hoff JT Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients Neurosurgery 2003 53 34-38 10.1227/ 01.NEU.0000068830.54968.A8 12823871
26. Lin J Hanigan WC Tarantino M Wang J The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: Preliminary findings J Neurosurg 2003 98 737-740 12691397
27. Heisel M Nagib M Madsen L Alshiekh M Bendel A Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients Pediatr Blood Cancer 2004 43 703-705 10.1002/pbc.20144 15390292
28. Karadimov D Binev K Nachkov Y Platikanov V Use of activated recombinant factor VII (NovoSeven) during neurosurgery J Neurosurg Anesthesiol 2003 15 330 332 10.1097/00008506-200310000-00008 14508176
29. Gerlach R Marquardt G Wissing H Scharrer I Raabe A Seifert V Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report J Neurosurg 2002 96 946-948 12005404
30. Veshchev I Elran H Salame K Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma Med Sci Monit 2002 8 CS98-CS100 12503044
31. Wong WY Huang WC Miller R McGinty K Whisnant JK Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency Haemophilia 2000 6 50-54 10.1046/j.1365-2516.2000.00345.x 10632743
32. Siegel LJ Gerigk L Tuettenberg J Dempfle CE Scharf J Fiedler F Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion Anesthesiology 2004 100 441-443 10.1097/ 00000542-200402000-00037 14739822
33. Pickard JD Kirkpatrick PJ Melsen T Andreasen RB Gelling L Fryer T Matthews J Minhas P Hutchinson PJ Menon D Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage Blood Coagul Fibrinolysis 2000 11 S117-S120 10850576
34. Pathak A Dutta S Marwaha N Singh D Varma N Mathuriya SN Change in tissue thromboplastin content of brain following trauma Neurol India 2005 53 178-182 16010055
35. Stein SC Smith DH Coagulopathy in traumatic brain injury Neurocrit Care 2004 1 479-488 10.1385/NCC:1:4:479 16174954
36. Kenet G Walden R Eldad A Martinowitz U Treatment of traumatic bleeding with recombinant factor VIIa Lancet 1999 354 1879 10.1016/ S0140-6736(99)05155-7 10584732
37. Hedner U Mechanism of action, development and clinical experience of recombinant FVIIa J Biotechnol 2006 124 747-757 10.1016/ j.jbiotec.2006.03.042 16697480
38. Levi M Bijsterveld NR Keller TT Recombinant factor VIIa as an antidote for anticoagulant treatment Semin Hematol 2004 41 65-69 10.1053/ j.seminhematol.2003.11.013 14872424
39. Deveras RA Kessler CM Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate Ann Intern Med 2002 137 884-888 12458988
40. Martinowitz U Zaarur M Yaron BL Blumenfeld A Martonovits G Treating traumatic bleeding in a combat setting: Possible role of recombinant activated factor VII Mil Med 2004 169 16-18 15651435
41. Warren O Mandal K Hadjianastassiou V Knowlton L Panesar S John K Darzi A Athanasiou T Recombinant activated factor VII in cardiac surgery: A systematic review Ann Thorac Surg 2007 83 707-714 10.1016/ j.athoracsur.2006.10.033 17258029
42. Segal S Shemesh IY Blumental R Yoffe B Laufer N Mankuta D Mazor M Zohar S Schiff E Martinovitz U The use of recombinant factor VIIa in severe postpartum hemorrhage Acta Obstet Gynecol Scand 2004 83 771-772 10.1111/ j.0001-6349.2004.00501.x 15255852
43. Ahonen J Jokela R Recombinant factor VIIa for life-threatening post-partum haemorrhage Br J Anaesth 2005 94 592-595 10.1093/bja/aei094 15708871
44. Welsby IJ Monroe DM Lawson JH Hoffmann M Recombinant activated factor VII and the anaesthetist Anaesthesia 2005 60 1203-1212 10.1111/ j.1365-2044.2005.04376.x 16288618
45. Midathada MV Mehta P Waner M Fink LM Recombinant factor VIIa in the treatment of bleeding Am J Clin Pathol 2004 121 124-137 10.1309/ D0G0-C96V-05CJ-5B4J 14750250
46. Arkin S Cooper HA Hutter JJ Miller S Schmidt ML Seibel NL Shapiro A Warrier I Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program Haemostasis 1998 28 93-98 10.1159/000022418 10087434
47. Roberts HR Recombinant factor VIIa: How safe is the stuff? Can J Anaesth 2005 52 8-11 15625249
48. Abshire T Kenet G Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors J Thromb Haemost 2004 2 899-909 10.1111/ j.1538-7836.2004.00759.x 15140125
49. Levy JH Fingerhut A Brott T Langbakke IH Erhardtsen E Porte RJ Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: Review of safety profile Transfusion 2006 46 919-933 10.1111/ j.1537-2995.2006.00824.x 16734808
50. Levi M Peters M Büller HR Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Crit Care Med 2005 33 883-890 10.1097/01.CCM.0000159087.85970.38 15818119
51. Levi M Recombinant factor VIIa: A general hemostatic agent? Not yet J Thromb Haemost 2004 2 1695-1697 10.1111/j.1538-7836.2004.00912.x 15456476
52. Roberts HR Monroe DM 3rd Hoffman M Safety profile of recombinant factor VIIa Semin Hematol 2004 41 101-108 10.1053/j.seminhematol.2003.11.019 14872430
53. O'Connell KA Wood JJ Wise RP Lozier JN Braun MM Thromboembolic adverse events after use of recombinant human coagulation factor VIIa JAMA 2006 295 293-298 10.1001/jama.295.3.293 16418464
54. Hoffman M, Monroe DM 3rd: A cell-based model of hemostasis. Thromb Haemost 2001, 85:958-965.
55. Romano JG Forteza AM Concha M Koch S Heros RC Morcos JJ Babikian VL Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage Neurosurgery 2002 50 1026-1030 10.1097/00006123-200205000-00016 11950405
56. Thomas GO Dutton RP Hemlock B Stein DM Hyder M Shere-Wolfe R Hess JR Scalea TM Thromboembolic complications associated with Factor VII administration J Trauma 2007 62 564-569 17414329